Shares of Illumina (ILMN) have soared from $210 to $350 as demand for genome machines and consumables continue to climb.
Ilumina (ILMN) has gone from $175 to $270 in a year, and with a P/E of 56 the stock is quite pricey. Let’s take a quick look.
Illumina (ILMN) makes gene-sequencing machines used to analyze DNA. ILMN’s new NovaSeq machines are so good customers are upgrading.
Illumina (ILMN) is expected to have accelerating profit growth in 2018 as its new gene sequencing system is generating momentum. But is the good news priced into ILMN stock?
Shares of Illumina (ILMN) broke out and went into All-Time high territory after the company said demand for its new NovaSeq machine has been solid.